Norbert W. Bischofberger
2009
In 2009, Norbert W. Bischofberger earned a total compensation of $4.2M as Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $550,800 |
|---|---|
| Option Awards | $1,333,459 |
| Salary | $677,923 |
| Stock Awards | $1,633,990 |
| Other | $5,400 |
| Total | $4,201,572 |
Bischofberger received $1.6M in stock awards, accounting for 39% of the total pay in 2009.
Bischofberger also received $550.8K in non-equity incentive plan, $1.3M in option awards, $677.9K in salary and $5.4K in other compensation.
Rankings
In 2009, Norbert W. Bischofberger's compensation ranked 953rd out of 9,885 executives tracked by ExecPay. In other words, Bischofberger earned more than 90.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 953 out of 9,885 | 90th |
Division Manufacturing | 325 out of 3,690 | 91st |
Major group Chemicals And Allied Products | 77 out of 866 | 91st |
Industry group Drugs | 50 out of 638 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 5 out of 133 | 96th |
Source: SEC filing on March 20, 2012.
Bischofberger's colleagues
We found five more compensation records of executives who worked with Norbert W. Bischofberger at Gilead Sciences in 2009.
2009
John Martin
Gilead Sciences
Chief Executive Officer
2009
John Milligan
Gilead Sciences
Chief Operating Officer
2009
Kevin Young
Gilead Sciences
Executive Vice President, Commercial Operations
2009
Gregg Alton
Gilead Sciences
Executive Vice President, Corporate and Medical Affairs
2009
Robin Washington
Gilead Sciences